VaxThera and Codagenix Partner to Advance a Next Generation Yellow Fever Vaccine
VaxThera will further advance Syn17D-YF, the world's first fully synthetic yellow fever vaccine candidate designed for modern cell-culture manufacturing FARMINGDALE, N.Y., Sept. 15, 2026 /PRNewswire/ -- VaxThera S.A.S., a Colombian biotechnology company developing and manufacturing...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.